The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin

Clinical Endocrinology

Volumn 74, Issue 1, 2011, Pages 67-72

  Roberts, R E ^a   Glicksman, C ^b   Alaghband Zadeh, J ^b   Sherwood, R A ^b   Akuji, N ^a   Le Roux, C W ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLYCOCHENODEOXYCHOLIC ACID; GLYCODEOXYCHOLIC ACID; LITHOCHOLIC ACID; PEPTIDE YY; TAUROCHENODEOXYCHOLIC ACID; TAURODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CHEMICAL STRUCTURE; GHRELIN BLOOD LEVEL; GLUCAGON LIKE PEPTIDE 1 BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PEPTIDE YY BLOOD LEVEL; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADULT; BILE ACIDS AND SALTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLYCOCHENODEOXYCHOLIC ACID; HUMANS; MALE; PEPTIDE YY; POSTPRANDIAL PERIOD; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 78650325228     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03886.x     Document Type: Article

References (46)

1. Gupta, S., Stravitz, R.T., Dent, P., et al. (2001) Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. Journal of Biological Chemistry, 276, 15816-15822.
2. Qiao, L., Han, S.I., Fang, Y., et al. (2003) Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Molecular and Cellular Biology, 23, 3052-3066.
3. Maruyama, T., Miyamoto, Y., Nakamura, T., et al. (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochemical and Biophysical Research Communications, 298, 714-719.
4. Kawamata, Y., Fujii, R., Hosoya, M., et al. (2003) A G protein-coupled receptor responsive to bile acids. Journal of Biological Chemistry, 278, 9435-9440.
5. Parks, D.J., Blanchard, S.G., Bledsoe, R.K., et al. (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science, 284, 1365-1368.
6. Makishima, M., Okamoto, A.Y., Repa, J.J., et al. (1999) Identification of a nuclear receptor for bile acids. Science, 284, 1362-1365.
7. Mangelsdorf, D.J., Thummel, C., Beato, M., et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
8. Watanabe, M., Houten, S.M., Mataki, C., et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature, 439, 484-489.
9. Holt, J.A., Luo, G., Billin, A.N., et al. (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes and Development, 17, 1581-1591.
10. Inagaki, T., Choi, M., Moschetta, A., et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metabolism, 2, 217-225.
11. Tomlinson, E., Fu, L., John, L., et al. (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology, 143, 1741-1747.
12. Shaham, O., Wei, R., Wang, T.J., et al. (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Molecular Systems Biology, 4, 214.
13. Ikemoto, S., Takahashi, M., Tsunoda, N., et al. (1997) Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. American Journal of Physiology, 273, E37-E45.
14. Garg, A., &, Grundy, S.M., (1994) Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial. Annals of Internal Medicine, 121, 416-422.
15. Goldberg, R.B., Fonseca, V.A., Truitt, K.E., et al. (2008) Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Archives of Internal Medicine, 168, 1531-1540.
16. Fonseca, V.A., Rosenstock, J., Wang, A.C., et al. (2008) Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care, 31, 1479-1484.
17. Yamagata, K., Daitoku, H., Shimamoto, Y., et al. (2004) Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. Journal of Biological Chemistry, 279, 23158-62315.
18. Han, S.I., Studer, E., Gupta, S., et al. (2004) Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes. Hepatology, 39, 456-463.
19. Trottier, J., Milkiewicz, P., Kaeding, J., et al. (2006) Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Molecular Pharmaceutics, 3, 212-222.
20. Anini, Y., Fu-Cheng, X., Cuber, J.C., et al. (1999) Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers Archiv. European Journal of Physiology, 438, 299-306.
21. Adrian, T.E., Ballantyne, G.H., Longo, W.E., et al. (1993) Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut, 34, 1219-1224.
22. Katsuma, S., Hirasawa, A., &, Tsujimoto, G., (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochemical and Biophysical Research Communications, 329, 386-390. (Pubitemid 40255465)
23. Mason, E.E., (1999) Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obesity Surgery, 9, 223-228.
24. Patti, M.E., Houten, S.M., Bianco, A.C., et al. (2009) Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity, 17, 1671-1677.
25. Bray, G.A., &, Gallagher, T.F.J., (1968) Suppression of appetite by bile acids. Lancet, 1, 1066-1067.
26. Soper, N.J., Chapman, N.J., Kelly, K.A., et al. (1990) The 'ileal brake' after ileal pouch-anal anastomosis. Gastroenterology, 98, 111-116.
27. Ballantyne, G.H., Longo, W.E., Savoca, P.E., et al. (1989) Deoxycholate-stimulated release of peptide YY from the isolated perfused rabbit left colon. American Journal of Physiology, 257, G715-G724.
28. Wen, J., Phillips, S.F., Sarr, M.G., et al. (1995) PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. American Journal of Physiology. Gastrointestinal and Liver Physiology, 269, G945-G952.
29. Aponte, G.W., Fink, A.S., Meyer, J.H., et al. (1985) Regional distribution and release of peptide YY with fatty acids of different chain length. American Journal of Physiology, 249, G745-G750.
30. Armstrong, D.N., Krenz, H.K., Modlin, I.M., et al. (1993) Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum. Gut, 34, 483-488.
31. Dietschy, J.M., (1968) Mechanisms for the intestinal absorption of bile acids. Journal of Lipid Research, 9, 297-309.
32. Plaisancié, P., Dumoulin, V., Chayvialle, J.A., et al. (1996) Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. Journal of Endocrinology, 151, 421-429.
33. Cummings, D.E., Weigle, D.S., Frayo, R.S., et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
34. Date, Y., Kojima, M., Hosoda, H., et al. (2000) Ghrelin, a novel growth-hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 141, 4255-4261.
35. Cummings, D.E., Purnell, J.Q., Frayo, R.S., et al. (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 50, 1714-1719.
36. Cummings, D.E., &, Shannon, M.H., (2003) Roles for ghrelin in the regulation of appetite and body weight. Archives of Surgery, 138, 389-396.
37. Tschöp, M., Wawarta, R., Riepl, R.L., et al. (2001) Post-prandial decrease of circulating human ghrelin levels. Journal of Endocrinological Investigation, 24, RC19-RC21. (Pubitemid 32573786)
38. Drazen, D.L., Vahl, T.P., D'Alessio, D.A., et al. (2006) Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology, 147, 23-30.
39. Theander-Carrillo, C., Wiedmer, P., Cettour-Rose, P., et al. (2006) Ghrelin action in the brain controls adipocyte metabolism. Journal of Clinical Investigation, 116, 1983-1993.
40. Tschöp, M., Weyer, C., Tataranni, P.A., et al. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709. (Pubitemid 32242624)
41. Cremonini, F., Camilleri, M., Vazquez Roque, M., et al. (2006) Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology, 131, 1431-1439.
42. Tagliacozzi, D., Mozzi, A.F., Casetta, B., et al. (2003) Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clinical Chemistry and Laboratory Medicine, 41, 1633-1641.
43. Adrian, T.E., Ferri, G.L., Bacarese-Hamilton, A.J., et al. (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology, 89, 1070-1077.
44. Kreymann, B., Williams, G., Ghatei, M.A., et al. (1987) Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet, 330, 1300-1304.
45. Patterson, M., Murphy, K.G., le Roux, C.W., et al. (2005) Characterization of ghrelin-like immunoreactivity in human plasma. Journal of Clinical Endocrinology and Metabolism, 90, 2205-2211.
46. Date, Y., Toshinai, K., Koda, S., et al. (2005) Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology, 146, 3518-3525.